What We’re Doing for World Alzheimer’s Month 2022
September is World Alzheimer’s Month, and people from all over the world come together through walks and fundraisers to help increase awareness of the disease. The 2022 theme is “Know Dementia, Know Alzheimer’s,” with a focus on the idea that we may be able to make a greater impact if we can find the early warning signs for Alzheimer’s Disease.
IMA Clinical Research works with pharmaceutical companies to find possible causes of Alzheimer’s, as well as treatments that may prevent Alzheimer’s from developing, through our various clinical trials. We also support the Alzheimer’s Association year-round through various events as we fight to end Alzheimer’s.
Walk to End Alzheimer’s
Every year, the Alzheimer’s Association holds the Walk to End Alzheimer’s (WTEA) to raise awareness and money to accelerate global research, maximize quality care and support and help millions who suffer today. You can find a walk near you at act.alz.org.
This year, our sites in New Jersey, West Virginia, and Albuquerque are proud sponsors of these walks, and we recognize this as a great opportunity for us to connect patients, their caregivers and healthy lifestyle volunteers to clinical trials that advance Alzheimer’s disease research.
Prime Time Publishing 50+ Expo
The 50+ Expo is a free health fair in New Mexico run by Prime Time Publishing. Attendees of the expo could help advance treatments for Alzheimer’s by participating in our clinical trials. Physicians will be available to answer questions and perform simple tests to determine eligibility. If you pass the initial screening, office visits can be scheduled.
Volunteers helping IMA Clinical Research study Alzheimer’s will help evaluate the safety and efficacy of innovative medical treatments and will help determine whether a specific product can prevent Alzheimer’s disease from developing.
Understanding Alzheimer’s Disease
More than six million Americans are currently affected by Alzheimer’s, and that number is expected to rise to approximately fourteen million by the year 2050. Alzheimer’s is the sixth-leading cause of death in the United States, and it’s the only illness in the country’s top ten causes of death that isn’t preventable. If you want a deeper dive into learning more about Alzheimer’s and the research underway to prevent and treat the disease, our June 2022 blog, “Understanding Alzheimer’s Disease,” is a great resource.
Interested in participating in one of these innovative trials? Contact us today to find out if you qualify.